Krykowski E - Search Results

1

Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.

Smolewski P, Niewiadomska H, Błonski JZ, Robak T, Krykowski E. Smolewski P, et al. Among authors: krykowski e. Neoplasma. 1998;45(3):140-7. Neoplasma. 1998. PMID: 9717525

2

Expression of p21 and MDM-2 proteins on tumor cells in responding and non-responding patients with Hodgkin's disease.

Smolewski P, Niewiadomska H, Krykowski E, Robak T. Smolewski P, et al. Among authors: krykowski e. Neoplasma. 1999;46(4):212-8. Neoplasma. 1999. PMID: 10613600

3

Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.

Smolewski P, Robak T, Krykowski E, Blasiñska-Morawiec M, Niewiadomska H, Pluzanska A, Chmielowska E, Zambrano O. Smolewski P, et al. Among authors: krykowski e. Clin Cancer Res. 2000 Mar;6(3):1150-60. Clin Cancer Res. 2000. PMID: 10741746

4

Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system.

Kalinka E, Robak T, Wrzesien-Kus A, Krykowski E, Warzocha K. Kalinka E, et al. Among authors: krykowski e. Ann Hematol. 2002 May;81(5):289-91. doi: 10.1007/s00277-002-0445-8. Epub 2002 Apr 5. Ann Hematol. 2002. PMID: 12029540

5

Combination regimen of 2-chlorodeoxyadenosine (cladribine), mitoxantrone and dexamethasone (CMD) in the treatment of refractory and recurrent low grade non-Hodgkin's lymphoma.

Robak T, Gora-Tybor J, Urbańska-Ryś H, Krykowski E. Robak T, et al. Among authors: krykowski e. Leuk Lymphoma. 1999 Jan;32(3-4):359-63. doi: 10.3109/10428199909167397. Leuk Lymphoma. 1999. PMID: 10037034 Clinical Trial.

6

Characterization of proteins from chronic lymphocytic leukaemic cells: electrophoretic and immunological approach.

Chruściel J, Błoński J, Krykowski E, Mirowski M, Hanausek M, Kiliańska ZM. Chruściel J, et al. Among authors: krykowski e. Cytobios. 1996;85(340):39-49. Cytobios. 1996. PMID: 8771767

7

Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome.

Robak T, Urbańska-Ryś H, Strzelecka B, Krykowski E, Bartkowiak J, Bĺoński JZ, Kordek R, Warzocha K. Robak T, et al. Among authors: krykowski e. Eur J Haematol. 2001 Nov-Dec;67(5-6):322-7. doi: 10.1034/j.1600-0609.2001.00592.x. Eur J Haematol. 2001. PMID: 11872081

8

2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.

Krykowski E, Warzocha K, Robak T. Krykowski E, et al. Arch Immunol Ther Exp (Warsz). 1995;43(5-6):317-21. Arch Immunol Ther Exp (Warsz). 1995. PMID: 8744653

9

Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).

Góra-Tybor J, Krykowski E, Robak T. Góra-Tybor J, et al. Among authors: krykowski e. Arch Immunol Ther Exp (Warsz). 1996;44(4):255-8. Arch Immunol Ther Exp (Warsz). 1996. PMID: 9017166

10

Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three cases.

Blasińska-Morawiec M, Robak T, Krykowski E, Hellmann A, Urbańska-Ryś H. Blasińska-Morawiec M, et al. Among authors: krykowski e. Leuk Lymphoma. 1997 Apr;25(3-4):381-5. doi: 10.3109/10428199709114177. Leuk Lymphoma. 1997. PMID: 9168448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters